Minet Valentine, Dogné Jean-Michel, Mullier François
Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur 5000, Belgium.
CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Hematology Laboratory, Université catholique de Louvain, Yvoir 5530, Belgium.
Molecules. 2017 Apr 11;22(4):617. doi: 10.3390/molecules22040617.
A rapid and accurate diagnosis in patients with suspected heparin-induced thrombocytopenia (HIT) is essential for patient management but remains challenging. Current HIT diagnosis ideally relies on a combination of clinical information, immunoassay and functional assay results. Platelet activation assays or functional assays detect HIT antibodies that are more clinically significant. Several functional assays have been developed and evaluated in the literature. They differ in the activation endpoint studied; the technique or technology used; the platelet donor selection; the platelet suspension (washed platelets, platelet rich plasma or whole blood); the patient sample (serum or plasma); and the heparin used (type and concentrations). Inconsistencies in controls performed and associated results interpretation are common. Thresholds and performances are determined differently among papers. Functional assays suffer from interlaboratory variability. This lack of standardization limits the evaluation and the accessibility of functional assays in laboratories. In the present article, we review all the current activation endpoints, techniques and methodologies of functional assays developed for HIT diagnosis.
对疑似肝素诱导的血小板减少症(HIT)患者进行快速准确的诊断对患者管理至关重要,但仍具有挑战性。目前,HIT的诊断理想情况下依赖于临床信息、免疫测定和功能测定结果的综合判断。血小板激活测定或功能测定可检测出更具临床意义的HIT抗体。文献中已开发并评估了几种功能测定方法。它们在研究的激活终点、使用的技术或工艺、血小板供体选择、血小板悬液(洗涤血小板、富血小板血浆或全血)、患者样本(血清或血浆)以及所用肝素(类型和浓度)等方面存在差异。对照操作和相关结果解释的不一致很常见。不同论文中确定的阈值和性能也有所不同。功能测定存在实验室间的变异性。这种缺乏标准化的情况限制了功能测定在实验室中的评估和应用。在本文中,我们回顾了目前为HIT诊断开发的功能测定的所有激活终点、技术和方法。